Free tool
Rare disease stocks
We cover 9 companies grouped under the Rare disease theme. The median market value in the group is $547.34M. Across the group, the median move over the past trading day is −0.53%. Price change over the past year runs from −35.9% to +30.5% across the middle 80 percent of the group, with a median of −2.6%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
9 of 268 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| NEU.AX | Neuren Pharmaceuticals Limited | $1.88B | Small cap | +5.54% |
| PYC.AX | PYC Therapeutics Limited | $1.60B | Small cap | +74.42% |
| 4516.T | Nippon Shinyaku Co., Ltd. | $1.52B | Small cap | +19.48% |
| 006280.KS | GC Biopharma Corp. | $1.06B | Small cap | −2.60% |
| 005257.KS | GC Corp. | $547.34M | Small cap | −40.16% |
| 4552.T | JCR Pharmaceuticals Co., Ltd. | $406.58M | Small cap | −9.63% |
| CUV.AX | Clinuvel Pharmaceuticals Limited | $338.48M | Small cap | −24.94% |
| 4599.T | StemRIM | $140.21M | Small cap | +14.75% |
| DXB.AX | Dimerix Limited | $122.97M | Small cap | −34.83% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.